Sign in

CIK 0000715446

  • Non-accelerated filer
  • Smaller reporting company

Anixa Biosciences Inc

Sign in to watch
Ticker
ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Oct 31
Incorporated
DE
Entity type
Operating
EIN
112622630
Phone
+1 408-708-9808
Business address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
Former names
ITUS Corp, COPYTELE INC
  1. 4 Other acquisition President and CEO acquired 5,236 shares (other)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market sale VP Finance and CFO sold 92,450 shares at an average $0.21 ($19,359)
  8. 4 Exercise or conversion Director acquired 1,400,000 shares (option exercise)
  9. 4 Exercise or conversion VP Finance and CFO acquired 280,000 shares (option exercise)
  10. 4 Other acquisition President and CEO acquired 3,447 shares (other)
  11. 4 Other acquisition Director acquired 6,894 shares (other)
  12. 4 Exercise or conversion Director acquired 700,000 shares (option exercise)
  13. 4 Open-market buy Director bought 24,973 shares at $0.30 ($7,492)
  14. 4 Open-market buy Director bought 25,000 shares at $0.31 ($7,750)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 19 of 24 · 471 filings